Clinical Trial Update: Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 trial of risedronate for prevention of osteoporosis in osteopenic postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED